Biology & Philosophy

, 34:17 | Cite as

Lamarckian or not, CRISPR-Cas is an elaborate engine of directed evolution

  • Eugene V. KooninEmail author

I appreciate the interest of many biologists and philosophers of biology in my discussion of the conceptual and philosophical aspects of CRISPR-Cas (Koonin 2018) and their insightful comments. Perhaps, not surprisingly, the primary topic that is addressed in 4 of the 6 commentaries is my proposition that the evolutionary changes mediated by the CRISPR-Cas systems are of the Lamarckian character. It is interesting that two of these commentaries (Wideman et al. 2018; Woolley et al. 2018) object (strenuously, in the latter case) to the characterization of the CRISPR-Cas systems as engines of Lamarckian evolution, whereas the other two (Jablonka 2018; Veigl 2018) largely concur with my view and extend it. Perhaps, this also should have been anticipated because Lamarckian evolution is a perpetually controversial subject, and as aptly noticed by Jablonka, many biologists have a “knee-jerk” reaction to the very name “Lamarck”. In this brief response, I first address the two “anti-Lamarckian”...



I would like to once again thank all the commentators for their insights that vindicate the very effort of writing the target article. Funding was provided by U.S. Department of Health and Human Services (Inramural funds).


  1. Caplan AL, Parent B, Shen M, Plunkett C (2015) No time to waste—the ethical challenges created by CRISPR: CRISPR/Cas, being an efficient, simple, and cheap technology to edit the genome of any organism, raises many ethical and regulatory issues beyond the use to manipulate human germ line cells. EMBO Rep 16:1421–1426CrossRefGoogle Scholar
  2. Faure G, Makarova KS, Koonin EV (2019) CRISPR-Cas: complex functional networks and multiple roles beyond adaptive immunity. J Mol Biol 431:3–20CrossRefGoogle Scholar
  3. Jablonka E (2018) Lamarckian realities: the CRISPR-Cas system and beyond. Philos Biol. CrossRefGoogle Scholar
  4. Koonin EV (2011) The logic of chance: the nature and origin of biological evolution. FT Press, Upper Saddle RiverGoogle Scholar
  5. Koonin EV (2018) CRISPR: a new principle of genome engineering linked to conceptual shifts in evolutionary biology. Philos Biol. CrossRefGoogle Scholar
  6. Koonin EV, Makarova KS (2018) Discovery of oligonucleotide signaling mediated by CRISPR-associated polymerases solves two puzzles but leaves an enigma. ACS Chem Biol 13:309–312CrossRefGoogle Scholar
  7. Koonin EV, Wolf YI (2009) Is evolution Darwinian or/and Lamarckian? Biol Direct 4:42CrossRefGoogle Scholar
  8. Koonin EV, Wolf YI (2016) Just how Lamarckian is CRISPR-Cas immunity: the continuum of evolvability mechanisms. Biol Direct 11:9CrossRefGoogle Scholar
  9. Nei M (2013) Mutation-driven evolution. Oxford University Press, OxfordGoogle Scholar
  10. Shmakov S, Smargon A, Scott D, Cox D, Pyzocha N, Yan W, Abudayyeh OO, Gootenberg JS, Makarova KS, Wolf YI et al (2017) Diversity and evolution of class 2 CRISPR-Cas systems. Nat Rev Microbiol 15:169–182CrossRefGoogle Scholar
  11. Shmakov SA, Makarova KS, Wolf YI, Severinov KV, Koonin EV (2018) Systematic prediction of genes functionally linked to CRISPR-Cas systems by gene neighborhood analysis. Proc Natl Acad Sci USA 115:E5307–E5316CrossRefGoogle Scholar
  12. Staals RH, Jackson SA, Biswas A, Brouns SJ, Brown CM, Fineran PC (2016) Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR-Cas system. Nat Commun 7:12853CrossRefGoogle Scholar
  13. Veigl SJ (2018) A use/disuse paradigm for CRISPR-cas systems. Philos Biol. CrossRefGoogle Scholar
  14. Wideman JG, Inkpen SA, Doolittle WF, Redfield RJ (2018) Mutationism, not Lamarckism, captures the novelty of CRISPR-Cas. Philos Biol. CrossRefGoogle Scholar
  15. Woolley S, Parke EC, Kelley D, Poole AM, Ganley A (2018) Striving for clarity about the “Lamarckian” nature of CRISPR-Cas systems. Philos Biol. CrossRefGoogle Scholar
  16. Xu X, Qi LS (2018) A CRISPR-dCas toolbox for genetic engineering and synthetic biology. J Mol Biol 431(1):34–47CrossRefGoogle Scholar

Copyright information

© This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2019

Authors and Affiliations

  1. 1.National Center for Biotechnology Information, National Library of MedicineBethesdaUSA

Personalised recommendations